2024 Medical Device Giants' M&A Landscape: Strategic Acquisitions Reshape the Industry

▲Source of the article: Eshare Medical Device Hub

▲Please indicate the above source at the beginning of the article when reprinting.

In 2024, the medical device industry witnessed an unprecedented wave of mergers and acquisitions. Industry giants actively engaged in consolidating resources, expanding markets, and seizing technological high grounds through acquisitions, resulting in several high-profile major transactions.

Boston Scientific: A Firm Practitioner of Specialized Innovation

In 2024, Boston Scientific completed four major acquisitions, with a total transaction value of nearly $5.3 billion.Yuan. These mergers and acquisitions involve multiple fields such as urinary health and stroke prevention.

1. Axonics, Inc.

• Announcement Date: January 8, 2024

• Completion Date: November 15, 2024

• Transaction Amount: $3.7 Billion

• Background: Focus on the Sacral Neuromodulation (SNM) system, mainly used for treating urinary and bowel dysfunctions such as incontinence.

• Significance: This acquisition enabled Boston Scientific to successfully expand its urology health product line and enter the rapidly growing sacral neuromodulation market.

2. Silk Road Medical

• Announcement Date: June 18, 2024

• Completion Date: September 17, 2024

• Transaction Amount: $1.6 Billion

• Background: A minimally invasive surgical platform focused on the treatment of carotid artery disease, with technology aimed at preventing strokes.

• Significance: This acquisition strengthens Boston Scientific's technological reserves in the field of stroke prevention and further expands its product portfolio for vascular interventional treatments.

3. Cortex, Inc.

• Announcement Date: November 4, 2024

• Expected completion time: First half of 2025

• Transaction Amount: Undisclosed

• Background: Cortex has developed the OptiMap™ system, providing personalized ablation strategies for complex atrial fibrillation cases.

• Significance: Boston Scientific has entered the complex atrial fibrillation treatment field by leveraging this opportunity, enhancing its technical competitiveness in rhythm management.

4. Intera Oncology, Inc.

• Announcement Date: November 25, 2024

• Expected Completion Time: First Half of 2025

• Transaction Amount: Undisclosed

• Background: This company focuses on hepatic artery infusion therapy, mainly used for interventional tumor treatment.

• Significance: Further enriches Boston Scientific's product line in the field of cancer treatment.

GE Healthcare: Focusing on AI and Imaging Solutions

GE Healthcare's Three M&A Events in 2024 Showcase Its Deep Expertise in Medical Imaging, AI Solutions, and Nuclear Medicine.

1. MIM Software

• Announcement Date: January 8, 2024

• Transaction Amount: Undisclosed

• Background: Enhancing medical imaging analysis and AI digital workflow solutions.

• Significance: This acquisition further enhances GE Healthcare's intelligence level in imaging equipment and strengthens its competitiveness in the digital healthcare field.

2. Intelligent Ultrasound (Clinical AI Business)

• Announcement Date: July 18, 2024

• Transaction Amount: US$51 million

• Background: Focused on the development of AI-driven ultrasound image analysis tools.

• Significance: Through this acquisition, GE Healthcare further expands its leading advantage in the field of intelligent ultrasound equipment.

3. Nihon Medi-Physics

• Announcement Date: December 2024

• Transaction Amount: Undisclosed

• Background: Fully acquire Nihon Medi-Physics Co., Ltd. to strengthen its radiopharmaceuticals and nuclear medicine business.

• Significance: This acquisition will help GE Healthcare further expand its market share in the field of nuclear medicine.

Johnson & Johnson MedTech: Focusing on the Cardiovascular Field

In 2024, Johnson & Johnson completed two major acquisitions, each exceeding $1 billion, with a total transaction value of $14.8 billion.

1. Shockwave Medical

• Announcement Date: April 5, 2024

• Completion Date: June 15, 2024

• Transaction Amount: $13.1 Billion

• Background: Shockwave's core technology is Intravascular Lithotripsy (IVL), an innovative technology that treats calcified arterial plaque through sound waves.

• Significance: This acquisition further solidifies Johnson & Johnson's leading position in the field of cardiovascular disease treatment.

2. V-Wave

• Announcement Date: August 20, 2024

• Completion Date: October 10, 2024

• Transaction Amount: $1.7 Billion

• Background: V-Wave is an Israeli company focused on minimally invasive devices for treating chronic heart failure.

• Significance: Johnson & Johnson successfully entered the heart failure treatment market, further enhancing its cardiovascular disease portfolio.Treatment Solutions.

Medline: Consolidating Leadership in the Operating Room Consumables Market

In 2024, Medline completed a major acquisition worth $950 million, further solidifying its global leadership position in the surgical supplies market.

Acquisition of Ecolab's Surgical Solutions Business

• Agreement Date: April 2024

• Completion Date: August 1, 2024

• Transaction Amount: $950 Million

• Background: Ecolab's surgical solutions business mainly covers operating room cleaning, infection control, and other related consumables, aiming to improve the safety and efficiency of operating rooms.

• Meaning:Merit Medical through thisThe acquisition significantly strengthened its market competitiveness in the field of operating room infection control and consumables for infection prevention.

BD Acquires Edwards Lifesciences' Critical Care Division

• Announcement Date: June 1, 2024

• Completion Date: July 20, 2024

• Transaction Amount: $4.2 Billion

• Background: Covering blood flow monitoring and patient optimization solutions.

• Significance: The rapid growth of the intensive care market has significantly enhanced BD's competitiveness in this field.

Baxter Sells Renal Care Business for $3.8 Billion

• Announcement Date: May 2024

• Completion Date: August 2024

• Transaction Amount: $3.8 Billion

• Background: Baxter plans to focus its resources on high-growth areas such as robotic surgery and digital healthcare by selling non-core assets.

• Significance: This transaction provides financial support for Baxter's business transformation and also helps Carlyle Group expand its presence in the renal care treatment field.

Carl Zeiss Meditec Acquires D.O.R.C. for $1.07 Billion

• Announcement Date: March 2024

• Completion Date: June 2024

• Transaction Amount: USD 1.07 Billion

• Background: D.O.R.C. is one of the world's leading ophthalmic equipment companies, specializing in devices for retinal and cataract surgery.

• Significance: This acquisition further strengthens Carl Zeiss Meditec's market position in the field of ophthalmic surgical equipment, meeting the growing demand driven by the global aging trend.

Owens & Minor Acquires Rotech Healthcare

• Announcement Date: March 15, 2024

• Completion Date: September 5, 2024

• Transaction Amount: $1.5 billion

• Background: Expanding the home medical device business, focusing on oxygen therapy and respiratory care equipment.

• Significance: The rapid demand in the home healthcare marketRapid growth prompted this acquisition.

The Medical Device Industry in 2024 Sends a Strong Signal through M&A – Technological Innovation and Market Consolidation Are the Main Themes for the Future. In the coming years, as healthcare demands evolve and technology continues to advance, the wave of mergers and acquisitions in the medical device industry is likely to persist, bringing even more profound impacts.

Scan the QR code in the image below to purchase.

‍